Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
86 hedge funds and large institutions have $38.5M invested in Ampio Pharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 18 closing their positions.
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
48% more call options, than puts
Call options by funds: $719K | Put options by funds: $485K
21% more funds holding
Funds holding: 71 → 86 (+15)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $40.9M → $38.5M (-$2.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$9.78M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.97M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.77M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.21M |
| 5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$823K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.66M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$1.06M |
| 3 |
Goldman Sachs
New York
|
-$644K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$585K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$534K |
AMPE Hedge Fund Activity: Q2 2018 in Review
86 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2018, worth a combined $38.5M — down 5.8% from $40.9M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new AMPE positions and 18 closed out — a net gain of 15 holders — while 16 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $9.78M. The largest seller was Millennium Management, exiting entirely with an estimated $2.66M sold.
- 86 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2018, up from 71 in Q1 2018.
- Funds reported $38.5M of Ampio Pharmaceuticals Inc. stock for Q2 2018, down 5.8% quarter-over-quarter.
- 33 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2018 and 18 closed out, a net change of +15 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2018 was BlackRock, an estimated $9.78M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2018 was Millennium Management, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2018.